Evidence map›Paper›PMID 16504012›Full record

ArticleJournal of autoimmune diseases2006

Endothelial cell activation and neovascularization are prominent in dermatomyositis.

Kanneboyina Nagaraju, Lisa G Rider, Chenguang Fan, Yi-Wen Chen, Megan Mitsak, Rashmi Rawat, Kathleen Patterson, Cecilia Grundtman, Frederick W Miller, Paul H Plotz and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of autoimmune diseases, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. [Dermatomyositis and juvenile dermatomyositis].Zeitschrift fur Rheumatologie · 2023
    Review
  4. Review
  5. The role of interferons type I, II and III in myositis: A review.Brain pathology (Zurich, Switzerland) · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Risk factors and disease mechanisms in myositis.Nature reviews. Rheumatology · 2018
    Review
  10. Review
  11. The Vasculopathy of Juvenile Dermatomyositis.Frontiers in pediatrics · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Kanneboyina NagarajuChildren's National Medical Center, Research Center for Genetic Medicine, 111 Michigan Ave NW, Washington, DC 20010, USA. knagaraju@cnmcresearch.org
Lisa G Rider
Chenguang Fan
Yi-Wen Chen
Megan Mitsak
Rashmi Rawat
Kathleen Patterson
Cecilia Grundtman
Frederick W Miller
Paul H Plotz
Eric Hoffman
Ingrid E Lundberg
Children's National · USJohns Hopkins University · USKarolinska University Hospital · SENational Institute of Environmental Health Sciences · USBoston Children's Hospital · USNational Institutes of Health · US

Funding

A FUNCTIONAL GENOMICS HEART &LUNG DEVELOP. PROGRAMU01HL066614 · NHLBI · CHILDREN'S RESEARCH INSTITUTE · PI HOFFMAN, ERIC P · 2000 to 2003
$3.5M
Pathogenesis of autoimmune myositis: Role of MHC Class 1R01AR050478 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI NAGARAJU, KANNEBOYINA · 2005 to 2009
$1.9M
IMMUNOPATHOGEN AUTOIMMUNE INFLAMMATORY MYOPATHIES--POLYMYOSITIS/DERMATOMYOSITISZ01AR041074 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI PLOTZ, PAUL H. · 1988 to 2008
$388k
Immunopathogen Autoimmune Inflammatory Myopathies--polymyositis/dermatomyositisZIAAR041074 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI SARTORELLI, VITTORIO · 2009 to 2013
$58k
NHLBI NIH HHS U01 HL066614NIAMS NIH HHS R01 AR050478
6 · The paper itself

Abstract

backgroundWhile vascular and immune abnormalities are common in juvenile and adult dermatomyositis (DM), the molecular changes that contribute to these abnormalities are not clear. Therefore, we investigated pathways that facilitate new blood vessel formation and dendritic cell migration in dermatomyositis.

methodsMuscle biopsies from subjects with DM (9 children and 6 adults) and non-myositis controls (6 children and 7 adults) were investigated by immunohistochemistry using antibodies that recognize existing (anti-CD146) and newly formed blood vessels (anti-alphaVbeta3) and mature dendritic cells (anti-DC-LAMP). Blood vessel quantification was performed by digitalized image analysis. Additional muscle biopsies from subjects with adult DM and non-myositis controls were used for global gene expression profiling experiments.

resultsA significant increase in neovascularization was found in muscle biopsies of DM patients; neovascularization (alphaVbeta3 positive capillaries and vessels per muscle fiber) was much higher in juvenile than in adult DM patients (control vs juvenile DM: Mean +/- SE: 0.06 +/- 0.01 vs 0.6 +/- 0.05; p < 0.0001 and control vs adult DM: Mean +/- SE: 0.60 +/- 0.1 vs 0.75 +/- 0.1; p = 0.051). Gene expression analysis demonstrated that genes that participate not only in angiogenesis but also in leukocyte trafficking and the complement cascade were highly up regulated in DM muscle in comparison to age matched controls. DC-LAMP positive dendritic cells were highly enriched at perivascular inflammatory sites in juvenile and adult DM patients along with molecules that facilitate dendritic cell transmigration and reverse transmigration (CD142 and CD31).

conclusionThese results suggest active neovascularization and endothelial cell activation in both juvenile and adult DM. It is likely that close association of monocytes with endothelial cells initiate rapid dendritic cell maturation and an autoimmune response in DM.

Identifiers

PMID16504012
PMCPMC1397829
OpenAlexW1743112776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.